Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FDA Grants BOND-003 Fast Track & Breakthrough Designations..

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Dec 12, 2023 4:08pm

247 Views

Post# 35780732

RE:FDA Grants BOND-003 Fast Track & Breakthrough Designations..

Very good results, pretty much the same as ours, but these numerous treatments for elderly patients are very difficult. IMO. Older patients are more susceptible to infections or treatment complications after each treatment visit. I believe we are still #1. They could be second with N-803+ BCG. All IMHO. If they got BTD we should get BTD express being at 1-3 treatment solution not requiring endless maintenance treatments just to maintain a CR diagnosis.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments